임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 1/2상모집 예정· Myeloma MultipleEtenta-Isa-VRd in Newly Diagnosed High-Risk Multiple Myeloma
협력: 애브비, 사노피
- 1/2상모집 예정· Acute Lymphoblastic LeukemiaHEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
협력: 애브비, 아스트라제네카
- 1/2상모집 예정· Arthritis, RheumatoidA Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
리드: BMS
- 1/2상모집 예정· JAK1 GOFUpadacitinib in Treatment of JAK/STAT Pathway Disorders With Activating Mutations
협력: 애브비
- 1/2상모집 예정· Ovarian CancerSafety and Efficacy of Ubamatamab With First-line Chemotherapy in Ovarian Cancer
협력: 리제네론
- 1/2상모집 예정· Primary Open Angle Glaucoma (POAG)REGN22530 for Adults With Primary Open Angle Glaucoma or Ocular Hypertension
리드: 리제네론
- 1/2상모집 중· Hemophilia AA Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
리드: 로슈
- 1/2상모집 중· Antineutrophil Cytoplasmic Antibody-associated VasculitisCC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis
협력: BMS
- 1/2상모집 예정· Relapsed or Refractory Multiple MyelomaA Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
리드: 아스트라제네카
- 1/2상모집 중· Malignant NeoplasmA Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
리드: 머크(MSD)
- 1/2상모집 중· SCHIZOPHRENIA 1 (Disorder)A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia
협력: BMS
- 1/2상모집 중· Relapse Multiple MyelomaStudy of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma
협력: 사노피
- 1/2상모집 중· Advanced Solid TumorA First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
협력: 사노피
- 1/2상모집 중· Extensive-stage Small Cell Lung Cancer (ES-SCLC)A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy
리드: 노바티스
- 1/2상모집 예정· Lymphoma, Non-HodgkinA Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHL
리드: GSK
- 1/2상모집 중· Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung CancerRollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments
리드: 노바티스
- 1/2상모집 중· Respiratory Syncytial Virus Infections+MetapneumovirusA Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults
리드: GSK
- 1/2상모집 중· Metastatic Prostate CancerPhase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
리드: 아스트라제네카
- 1/2상모집 예정· B-cell Acute Lymphoblastic LeukemiaA Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia
협력: 암젠, 화이자
- 1/2상모집 예정· Metastatic Castration-Resistant Prostate Cancer (mCRPC)REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
리드: 리제네론
- 1/2상모집 중· Metastatic Prostate CancerFirst-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer
리드: 아스트라제네카
- 1/2상모집 중· Lymphoma, Non-HodgkinA Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
리드: 머크(MSD)
- 1/2상모집 중· Lung Neoplasm MalignantA Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
리드: 머크(MSD)
- 1/2상모집 중· Advanced Prostate CancerA Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
리드: 로슈
- 1/2상모집 예정· Recurrent Respiratory Papillomatosis (RRP)Efficacy of Booster Injection With Gardasil-9 Vaccine on Intersurgical Interval* for Adults With Recurrent Respiratory Papillomatosis*
협력: 머크(MSD)
- 1/2상모집 중· Thoracic Neoplasms, Lung Diseases, Small Cell Lung CarcinomaA Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
협력: 로슈
- 1/2상모집 중· Locally Advanced or Metastatic Solid TumorsBC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
협력: 머크(MSD)
- 1/2상모집 중· Advanced Solid Tumor CancerEarly-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors
리드: 바이오엔테크
- 1/2상모집 중· Oesophageal Squamous Cell CarcinomaA Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)
리드: 머크(MSD)
- 1/2상모집 중· Relapsed Refractory Multiple Myeloma (RRMM)A Trial to Study if REGN17372 in Combination With Linvoseltamab is Tolerable for Adult Participants With Relapsed/Refractory Multiple Myeloma
리드: 리제네론
- 1/2상모집 중· Advanced Renal Cell Carcinoma (RCC)A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
리드: BMS · 협력: 바이오엔테크
- 1/2상모집 중· Recurrent Multiple MyelomaResponse-Based Dose Reduction of Linvoseltamab in the Treatment of Relapsed, Refractory, or Triple-Class Relapsed/Refractory Multiple Myeloma
협력: 리제네론
- 1/2상모집 중· Hepatocellular Carcinoma (HCC)A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
리드: BMS · 협력: 바이오엔테크
- 1/2상모집 중· Urothelial CancerSymbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
리드: 화이자
- 1/2상모집 중· Carcinoma, Non-Small-Cell LungA Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer
리드: 얀센(J&J)
- 1/2상모집 중· Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaA Phase Ib/II Study of ATG-022 Plus Pembrolizumab With/Without Chemotherapy in Participants With Claudin (CLDN) 18.2-positive, HER2-negative, Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaUnresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
협력: 머크(MSD)
- 1/2상모집 중· Paroxysmal Nocturnal Hemoglobinuria (PNH)A First-in-Human Safety and Efficacy Study of ALN-CFB, a Small Interfering RNA (siRNA) Targeting Complement Factor B, in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria With Persistent Anemia on a C5 Inhibitor
리드: 리제네론
- 1/2상모집 중· Relapsed/Refractory Small Cell Lung CancerA Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
리드: BMS
- 1/2상모집 중· Advanced/Metastatic Non-Small Cell Lung CancerSymbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
리드: 화이자
- 1/2상모집 중· Small Cell Lung Cancer Extensive StageA Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
리드: 머크(MSD)
- 1/2상모집 중· Gastrointestinal CancerA Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors
협력: GSK
- 1/2상모집 중· Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
리드: 노바티스
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.